Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best Science Apps

More »
Jun 01, 2012 (Vol. 32, No. 11)

BioOncology HD

  • Nice user interface, good organization
  • Nothing major
Platform: iPad/iPhone  
Cost: Free

If you are looking to learn more about cell-signaling mechanisms involved in cancer, keep up with the latest news in cancer research, and follow clinical trials, then might I suggest the BioOncology HD app by Genentech. This sleekly designed app covers these things and more, such as a list of useful web links, as well as information about upcoming conferences and funding sources. A nice feature of the clinical trials resource is that it covers both Genentech and non-Genentech trials (though the default display is Genentech only). The “research” section of the app contains very nice animations depicting signaling pathways involved in cancer, such as apoptosis, angiogenesis, and the Hedgehog pathway. The “explore” feature is not too exciting—it only allows one to zoom in to the image—but the video animations make up for this shortcoming.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »